Chapter 7 The Emergence of GPR119 Agonists as Anti-Diabetic Agents

Seidell, 2000, Br. J. Nutr., 83, S5, 10.1017/S000711450000088X 1998, Lancet, 352, 854, 10.1016/S0140-6736(98)07037-8 Drucker, 2006, Cell Metab, 3, 153, 10.1016/j.cmet.2006.01.004 Drucker, 2006, Lancet, 368, 1696, 10.1016/S0140-6736(06)69705-5 Fredriksson, 2003, FEBS Lett, 554, 381, 10.1016/S0014-5793(03)01196-7 Soga, 2005, Biochem. Biophys. Res. Commun., 326, 744, 10.1016/j.bbrc.2004.11.120 Chu, 2007, Endocrinology, 148, 2601, 10.1210/en.2006-1608 Chu, 2008, Endocrinology, 149, 2038, 10.1210/en.2007-0966 Sakamoto, 2006, Biochem. Biophys. Res. Commun., 351, 474, 10.1016/j.bbrc.2006.10.076 Overton, 2006, Cell Metab, 3, 167, 10.1016/j.cmet.2006.02.004 Z. Chu, R. Jones, R. Chen, C. Carroll, V. Gutierrez, A. Lucman, D. P. Behan and J. Leonard, Keystone Symposium. Diabetes: Molecular Genetics, Signalling Pathways and Integrated Physiology, 2007, Abstract 230. L. Lauffer, R. Iakoubov and P. L. Brubaker, Diabetes, 2009 Feb 17. [Epub ahead of print] PMID: 19208912. Fu, 2007, J. Biol. Chem., 282, 1518, 10.1074/jbc.M607809200 Fu, 2003, Nature, 425, 90, 10.1038/nature01921 H. Lan, G. Vassileva, A. Corona, L. Liu, H. Baker, A. Golovko et al., Keystone Symposium. Diabetes: Molecular Genetics, Signalling Pathways and Integrated Physiology, 2007, Abstract 253. Ning, 2008, Br. J. Pharmacol., 155, 1056, 10.1038/bjp.2008.337 Huang, 2002, Proc. Natl. Acad. Sci. U.S.A., 99, 8400, 10.1073/pnas.122196999 Eisenhofer, 1997, J. Clin. Endocrinol. Metab., 82, 3864, 10.1210/jc.82.11.3864 Eldrup, 2000, Am. J. Physiol. Endocrinol. Metab., 279, E815, 10.1152/ajpendo.2000.279.4.E815 Parker, 2009, Diabetologia, 52, 289, 10.1007/s00125-008-1202-x C. Ammala, S. Bullard, J. Kashatus, S. Katamreddy, J. Way and A. Carpenter, Keystone Symposium, Islet and β-Cell Biology, 2008, Abstract #102. Semple, 2008, J. Med. Chem., 51, 5172, 10.1021/jm8006867 G. Semple, Abstracts of Papers, 41st Western Regional Meeting of the American Chemical Society, San Diego, CA, United States, October 9–13 2007, GEN-033. R. M. Jones, Abstracts of Papers, 232nd ACS National Meeting, San Francisco, CA, United States, Sept. 10–14, 2006, MEDI-275. Z. Chu, C. Carroll, V. Gutierrez, A. Lucman, M. Moloney, H. Gao et al., Keystone Symposium. Diabetes: Molecular Genetics, Signalling Pathways and Integrated Physiology, Keystone, Colorado, USA, 14–19 January 2007, Abstract 117. R. M. Jones and J. Lehmann, WO Patent Application 2007035355 A2, 2007. R. M. Jones and J. Lehmann, WO Patent Application 2008005576 A1, 2008. R. M. Jones, J. Lehmann and A. Siu-Ting Wong, WO Patent Application 2008005569 A2, 2008. J. Fang, J. Tang, A. J. Carpenter, G. Peckham, C. R. Conlee, S. K. Du and S. R. Katamreddy, WO Patent Application 2008070692, 2008. P. Brandt, G. Johansson, L. Johansson, T. Koolmeister, B. M. Nilsson and T. Sandvall, WO Patent Application 2008025799, 2008. D. A. Wacker, K. A. Rossi and Y. Wang, WO Patent Application 2009012277 A1, 2009. H. B. Wood, A. D. Adams, S. Freeman, J. W. Szewczyk, C. Santini and Y. Huang, WO Patent Application 2008085316 A1, 2008. Fyfe, 2006, Diabetes, 55 M. C. T. Fyfe, A. J. Babbs, L. S. Bertram, S. E. Bradley, S. M. Doel, S. Gadher, W. T. Gattrell, R. P. Jeevaratnam, J. F. Keily, J. G. McCormack, H. A. Overton, C. M. Rasamison, C. Reynet, C. P. Sambrook Smith, V. K. Shah, D. F. Stonehouse, S. A. Swain, J. R. White, P. S. Widdowson, G. M. Williams and M. J. Procter, Abstracts of Papers, 236th ACS National Meeting, Philadelphia, PA, United States, August 17–21, MEDI-197, 2008. A. Carpenter, C. Ammala, C. Briscoe, S. Bullard, J. Kashatus, S. Katamreddy, R. Mertz and S. Ross, Symposium, Islet and β-cell biology, 2008, Abstract #102. L. S. Bertram, M. C. T. Fyfe, M. J. Procter and G. M. Williams, WO Patent Application 2007116229 A1, 2007. R. M. Jones, G. Semple, Y. Xiong, Y-J Shin, A. S. Ren, I. Calderon, K. Choi, B. Fioravanti, J. Lehmann and M. A. Bruce, WO Patent Application 2005007647A1, 2005. R. M. Jones, G. Semple, Y. Xiong, Y-J Shin, A. S. Ren, I. Calderon and K. Choi, WO Patent Application 2005121121A2, 2005. R. M. Jones, J. Lehmann, A. Wong, D. Hirst and Y-J Shin, US Patent Application 2006155128 A1, 2006. R. M. Jones, J. Lehmann, A. Wong, D. Hirst and Y-J Shin, US Patent Application 2007167473 A1, 2007. R. M. Jones, G. Semple, Y. Xiong, Y-J Shin, A. S. Ren, I. Calderon, K. Choi, B. Fioravanti and C. R. Sage, WO Patent Application 2005007658 A2, 2005. X. Chen, P. Cheng, E.L. Clemens, J.D. Johnson, J. Ma, A. Murphy, I. Nashashibi, C.J. Rabbat, J. Song, M.E. Wilson, Y. Zhu and Z. Zhao, WO Patent Application 2008083238 A2, 2008. J. Ma, C. J. Rabbat, J. Song, X. Chen, I. Nashashibi, Z. Zhao, A. Novack, D.-F. Shi, P. Cheng, Y. Zhu and A. Murphy, WO Patent Application 2009014910 A2, 2009. P. B. Alper, G. Lelais, R. Epple and D. Mutnick, WO Patent Application 2008109702 A1, 2008. M. Wilson, F. Gregoire, B. Pandey, A. Chandalia, P. Zhang, O. Abdel-aleem, K. Marlen, E. Clemens, J. Johnson, X. Chen, J. Ma, I. Nashashibi, C. Rabbat, J. Song, A. Novack, D-F. Shi, S. Zhao and B. Lavan, Keystone Symposium, Type II Diabetes and Insulin Resistance, Banff, Canada, Abstract #369, January 2009. S. R. Katamreddy, R. D. Caldwell, D. Heyer, V. Samano, J. B. Thompson, A. J. Carpenter, C. R. Conlee, E. E. Boros and B. D. Thompson, WO Patent Application 2008008887 A2, 2008. C. Ammala and C. Briscoe, WO Patent Application 2008008895 A1, 2008. C. D. Boyle and B. R. Neustadt, WO Patent Application 2008130615 A1, 2008. C. D. Boyle, S. Chackalamannil, C. M. Lankin, U. Shah, B. R. Neustadt, H. Liu and A. W. Stamford, WO Patent Application 2008130584 A1, 2008. J. M. Fevig and D. A. Wacker, WO Patent Application 2008137436 A1, 2008. J. M. Fevig and D. A. Wacker, WO Patent Application 2008137435 A1, 2008. M. C. T. Fyfe, A. Babbs, L. S. Bertram, S. E. Bradley, S. M. Doel, S. Gadher, W. T. Gattrel, J. G. Horswill, R. P. Jeevaratnam, J. F. Keily, J. G. McCormack, H. A. Overton, C. M. Rasamison, C. Reynet, P. J. Rushworth, C. P. Sambrook Smith, V. K. Shah, D. F. Stonehouse, S. A. Swain, J. R. White, P. S. Widdowson, G. M. Williams and M. J. Proctor, Abstracts of Papers, 234th ACS National Meeting, Boston, MA, United States, August 19–23, 2007, MEDI-062. Fyfe, 2007, Diabetes, 56 M. C. T. Fyfe, J. White, P. Widdowson, H. Overton and C. Reynet, 67th Sessions ADA Meeting, Chicago, Illinois, USA, 2007. OSI Pharmaceuticals Initiates Clinical Development Program for Anti-Diabetes Candidate, PSN821, Company Press Release, September 3, 2008. M. C. T. Fyfe, J. Keily and S. A. Swain, WO Patent Application 2008081204 A1, 2008. L. S. Bertram, M. C. T. Fyfe, R. P. Jeevaratnam, J. Keily and S. A. Swain, WO Patent Application 2008081205 A1, 2008. M. C. T. Fyfe, J. Keily, M. Proctor, D. F. Stonehouse and S. A. Swain, WO Patent Application 2008081206 A1, 2008. M. C. T. Fyfe, R. P. Jeevaratnam, J. Keily and S. A. Swain, WO Patent Application 2008081207 A1, 2008. M. C. T. Fyfe, R. P. Jeevaratnam, J. Keily and S. A. Swain, WO Patent Application 2008081208 A1, 2008. P. Alper, M. Azimioara, C. Cow, R. Epple, S. Jiang, G. Leleais, P. Michellys, T. N. Nguyen, L. Westcott-Baker and B. Wu, WO Patent Application 2008097428 A2, 2008. T. Ohishi, J. Takasaki, M. Matsumoto, T. Saito, M. Kamohara, T. Soga, S. Yoshida and Y. Ueda, WO Patent Application 2002044362 A1, 2002. T. Ohishi, J. Takasaki, M. Matsumoto, T. Saito, M. Kamohara, T. Soga, S. Yoshida and Y. Ueda, EP Patent Application 1338651 A1. Arena Pharmaceuticals Announces Global Diabetes Collaboration with Ortho-McNeil Pharmaceutical, December 21, 2004, http://invest.arenapharm.com/releasedetail.cfm?ReleaseID=320780 Arena Pharmaceuticals Announces Selection of Two Arena-Discovered Compounds for Preclinical Development by Ortho-McNeil, December 23, 2004, http://invest.arenapharm.com/releasedetail.cfm?ReleaseID=320778 Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Arena Type 2 Diabetes Drug Candidate in Collaboration With Ortho-McNeil, February 7, 2006, http://invest.arenapharm.com/releasedetail.cfm?ReleaseID=320321 Arena Pharmaceuticals Announces That Ortho-McNeil Extends Research Term Under Partnership to Develop Drugs to Treat Type 2 Diabetes, September 27, 2006, http://invest.arenapharm.com/releasedetail.cfm?ReleaseID=320291. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes, January 7, 2008, http://invest.arenapharm.com/releasedetail.cfm?ReleaseID=320208 Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals, December 15, 2008, http://invest.arenapharm.com/releasedetail.cfm?ReleaseID=354391 Metabolex initiates Phase 1 Trial of MBX-2982, March 26, 2008, http://www.metabolex.com/news/mar262008.html S. Zhao, F. Gregoire, E. Clemens, D. Karpf, X. Chen, B. Lavan, J. Johnson and M. Wilson, The World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy). October 30–November 2, 2008, Barcelona, Spain. Metabolex Announces Positive Results from Phase 1a Clinical Trial of MBX-2982, November 12, 2008, http://www.metabolex.com/news/nov122008.html